Preclinical and clinical studies have shown that the use of prebiotics, probiotics, synbiotics, and conventional therapeutic strategies for DM, such as dietary changes, metformin, α-glucosidase inhibitors, and more recently, GLP-1 agonist administration can modulate microbiota composition in a more effective manner when compared to alternative strategies. Here, GCG is linked to diabetes mellitus.